קלרידקס

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

CLARITHROMYCIN

Διαθέσιμο από:

DEXCEL LTD, ISRAEL

Φαρμακολογική κατηγορία (ATC):

J01FA09

Φαρμακοτεχνική μορφή:

קפליות

Σύνθεση:

CLARITHROMYCIN 250 MG

Οδός χορήγησης:

פומי

Τρόπος διάθεσης:

מרשם נדרש

Κατασκευάζεται από:

DEXCEL LTD, ISRAEL

Θεραπευτική ομάδα:

CLARITHROMYCIN

Θεραπευτική περιοχή:

CLARITHROMYCIN

Θεραπευτικές ενδείξεις:

Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.

Ημερομηνία της άδειας:

2014-05-31